Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer.
Elizabeth Chabner(Dana-Farber Cancer Institute), Judy E. Garber(Dana-Farber Cancer Institute), Stuart J. Schnitt(Brigham and Women's Hospital), Abram Recht(Beth Israel Deaconess Medical Center), Rebecca Gelman(Dana-Farber Cancer Institute), Stella Hetelekidis(Dana-Farber Brigham Cancer Center), B. Silver(UMass Memorial Health Care), Judi Manola(Dana-Farber Cancer Institute), Asa J. Nixon(Dana-Farber Brigham Cancer Center), Jay R. Harris(Harvard University), James L. Connolly(Beth Israel Deaconess Medical Center), Bruce A. Bornstein(Harvard University)
Cited by 74
Related Papers
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
|The Lancet|2010|1.6k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Molecular characterization of the tumor microenvironment in breast cancer
|Cancer Cell|2004|1.3k